Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Recursion Pharmaceuticals
RXRX
$1.61B
| $621K | ﹤0.01% |
62,422
+25
| +0% | +$278 |
|
1902
Orion
OEC
$381M
| $620K | ﹤0.01% |
26,416
| – | – |
|
1903
Northwest Natural Holdings
NWN
$2.11B
| $620K | ﹤0.01% |
16,659
+1
| +0% | +$37 |
|
1904
Northwest Bancshares
NWBI
$2.3B
| $618K | ﹤0.01% |
53,124
+4
| +0% | +$47 |
|
1905
Kforce
KFRC
$1.02B
| $616K | ﹤0.01% |
8,752
+1
| +0% | +$68 |
|
1906
Green Plains
GPRE
$1.21B
| $615K | ﹤0.01% |
26,631
+28
| +0.1% | +$613 |
|
1907
ADMA Biologics
ADMA
$2.01B
| $615K | ﹤0.01% |
93,283
+11
| +0% | +$60 |
|
|
ZUO
1908
DELISTED
Zuora, Inc.
ZUO
| $614K | ﹤0.01% |
67,278
+18
| +0% | +$157 |
|
|
UNIT
1909
Uniti Group
UNIT
$2.26B
| $614K | ﹤0.01% |
104,309
+30
| +0% | +$171 |
|
1910
Appian
APPN
$1.94B
| $614K | ﹤0.01% |
15,370
-6
| -0% | -$208 |
|
1911
VSE Corp
VSEC
$5.37B
| $614K | ﹤0.01% |
7,681
| – | – |
|
1912
Tidewater
TDW
$3.65B
| $613K | ﹤0.01% |
6,670
-3
| -0% | -$224 |
|
|
PYCR
1913
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $610K | ﹤0.01% |
31,432
+23
| +0.1% | +$460 |
|
|
SHOE
1914
Shoe Station Group
SHOE
$420M
| $608K | ﹤0.01% |
16,611
+8,445
| +103% | +$250K |
|
1915
First Bancorp
FBNC
$2.61B
| $607K | ﹤0.01% |
16,833
| – | – |
|
|
PMT
1916
PennyMac Mortgage Investment
PMT
$812M
| $606K | ﹤0.01% |
41,326
+2
| +0% | +$29 |
|
1917
RELX
RELX
$63.9B
| $605K | ﹤0.01% |
13,975
-11
| -0.1% | -$465 |
|
1918
Harmonic Inc
HLIT
$1.22B
| $604K | ﹤0.01% |
45,004
+2
| +0% | +$26 |
|
|
KLG
1919
DELISTED
WK Kellogg Co
KLG
| $604K | ﹤0.01% |
32,135
-59,406
| -65% | -$864K |
|
|
MODN
1920
DELISTED
MODEL N, INC.
MODN
| $600K | ﹤0.01% |
21,074
+6
| +0% | +$158 |
|
1921
Safety Insurance
SAFT
$1.51B
| $598K | ﹤0.01% |
7,271
| – | – |
|
1922
Geron
GERN
$860M
| $597K | ﹤0.01% |
181,037
+19
| +0% | +$43 |
|
|
SMLR
1923
DELISTED
Semler Scientific
SMLR
| $596K | ﹤0.01% |
20,413
-860
| -4% | -$35.9K |
|
1924
Ovintiv
OVV
$17B
| $595K | ﹤0.01% |
11,470
-5,526
| -33% | -$252K |
|
|
CYBR
1925
DELISTED
CyberArk
CYBR
| $595K | ﹤0.01% |
2,239
| – | – |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.